Search - tctmd.com

Displaying 941 - 960 of 1360

Sort: Relevancy | Date

News Opinion Conversations in Cardiology

Conversations in Cardiology: Post-PCI Clopidogrel in CHAMPION PHOENIX Trial of Cangrelor

February 08, 2016

News Daily News

ROCKET AF Investigators: Problems With Warfarin Monitoring Device Did Not Skew Results

Todd Neale

February 04, 2016

News Daily News

分析显示中老年患者从机械主动脉瓣膜改用生物瓣膜可获改善

Caitlin E. Cox

January 20, 2016

News Daily News

Un Análisis Avala el Paso de Válvulas Aórticas Mecánicas a Bioprotésicas en Pacientes de Mediana Edad

Caitlin E. Cox

January 20, 2016

News Daily News

Shift From Mechanical to Bioprosthetic Aortic Valves in Middle-Aged Patients Gets Boost in Analysis

Caitlin E. Cox

January 20, 2016

News Daily News

FDA Grants Go-Ahead for Low-Risk TAVR Study

Shelley Wood

January 14, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Daily News

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

Yael L. Maxwell

December 22, 2015

News Daily News

Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines

Yael L. Maxwell

December 14, 2015

News Daily News

Societies Issue Recommendations for Operators, Institutions Offering LAA Closure Procedures

L.A. McKeown

December 10, 2015

News Industry News

Real-World Data Confirms Safety and Efficacy Profile of XARELTO®, With Shorter Hospital Stays, for the Treatment of Deep Vein Thrombosis

December 07, 2015

News Industry News

Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate)

November 29, 2015

News Daily News

关于人工生物瓣膜血栓形成的新发现可影响监测和研究

Caitlin E. Cox

November 23, 2015

News Daily News

Nuevos Hallazgos sobre la Trombosis de la Válvula Bioprotésica Tienen Implicaciones en Materia de Vigilancia e Investigación

Caitlin E. Cox

November 23, 2015

News Daily News

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

Caitlin E. Cox

November 23, 2015

News Industry News

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

November 19, 2015

News Daily News

Good News, Bad News Week for Watchman LAA Occluder

Shelley Wood

November 12, 2015

News Conference News AHA 2015

Reversal Agents Safely Stop Effects of Novel Oral Anticoagulants

Yael L. Maxwell

November 10, 2015

News Features

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Todd Neale

November 08, 2015

News Conference News AHA 2015

Is Watchman Cost-effective? That Depends Where You Look

Todd Neale

November 07, 2015

Advertisement

Conversations in Cardiology: Post-PCI Clopidogrel in CHAMPION PHOENIX Trial of Cangrelor

ROCKET AF Investigators: Problems With Warfarin Monitoring Device Did Not Skew Results

分析显示中老年患者从机械主动脉瓣膜改用生物瓣膜可获改善

Un Análisis Avala el Paso de Válvulas Aórticas Mecánicas a Bioprotésicas en Pacientes de Mediana Edad

Shift From Mechanical to Bioprosthetic Aortic Valves in Middle-Aged Patients Gets Boost in Analysis

FDA Grants Go-Ahead for Low-Risk TAVR Study

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines

Societies Issue Recommendations for Operators, Institutions Offering LAA Closure Procedures

Real-World Data Confirms Safety and Efficacy Profile of XARELTO®, With Shorter Hospital Stays, for the Treatment of Deep Vein Thrombosis

Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate)

关于人工生物瓣膜血栓形成的新发现可影响监测和研究

Nuevos Hallazgos sobre la Trombosis de la Válvula Bioprotésica Tienen Implicaciones en Materia de Vigilancia e Investigación

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

Good News, Bad News Week for Watchman LAA Occluder

Reversal Agents Safely Stop Effects of Novel Oral Anticoagulants

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Is Watchman Cost-effective? That Depends Where You Look

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content